The Global Liposomes Market Size is Predicted to Exceed USD 12.48 Billion by 2033, Growing at a CAGR of 5.94% from 2023 to 2033. The liposomes market growth is attributed to the increasing incidence of chronic diseases, the growing trend of nanotechnology and novel drug delivery systems, technological advancements in liposomal formulations, government financial support, and the rising proportion of molecular research findings.